Related Experiment Video
Updated: Aug 12, 2026

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
Advantages and guidelines for using opioid agonist-antagonist analgesics
1Department of Anesthesiology, University of Illinois, College of Veterinary Medicine, Urbana.
Opioid agonist-antagonists offer effective pain relief with lower abuse potential, making them non-controlled substances. They can reverse opioid agonist effects while maintaining some analgesia, with reduced respiratory depression.
Area of Science:
- Pharmacology
- Pain Management
- Addiction Medicine
Background:
- Opioid agonist-antagonists present a unique pharmacological profile with lower abuse potential compared to pure agonists.
- Their clinical utility lies in balancing analgesia with reduced risks of respiratory depression and dependence.
Framework:
- These agents act as agonists at one opioid receptor subtype and antagonists at another.
- This dual action allows for ceiling effects on analgesia and respiratory depression.
Implementation:
- Opioid agonist-antagonants are not classified as controlled substances, simplifying record-keeping and security measures.
- They are effective in managing moderate pain and can be used to counteract the adverse effects of opioid agonists.
Implications:
- Reduced potential for abuse and dependence offers a safer alternative for pain management.
- The ceiling effect on analgesia necessitates careful patient selection and consideration of alternative pain relief strategies.
Related Concept Videos
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids

